Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 21 Oct, 01:30 am
GE Aerospace (NYSE: GE) is set to report Q3 earnings with analysts expecting strong growth in EPS and revenue. Despite a history of beating estimates, the stock has seen declines post-earnings, highlighting investor focus on sustained growth in aftermarket services. The company f
Top Stock Gainers: Silence Therapeutics Leads on Merck Acquisition Silence Therapeutics (NASDAQ: SLN) surged after Merck KGaA agreed to acquire the company for approximately $1.30 billion in equity value. Disc Medicine (NASDAQ: IRON) rallied after its Phase 3 APOLLO trial met all
Top Stock Market Losers on October 19, 2026 Iambic Therapeutics (NASDAQ: IAM) fell sharply after its recent IPO but remained slightly above its $16.00 offering price. TCGX Acquisition (NASDAQ: TCGX) declined after announcing a business combination with TriGemX Bio. Cable One (NYS
Director Leon Borck recently increased his stake in Equity Bancshares (NYSE: EQBK) , signaling confidence in the company's future. The bank holding company reported robust third-quarter earnings , with net income of $26.8 million and core earnings of $1.40 per diluted share . Des
City Therapeutics (NASDAQ: CTY) IPO: RNAi Biotechnology Stock Makes Its Market Debut City Therapeutics (NASDAQ: CTY) priced its initial public offering at $18.00 per share , raising approximately $200.00 million in gross proceeds. The clinical-stage biotechnology company develops
ICICI Bank (NYSE: IBN) Beats Q2 FY2027 Estimates as Profit Rises 20.1% ICICI Bank (NYSE: IBN) reported ADR earnings of approximately $0.44 per share , above the roughly $0.41 estimate , while revenue of $3.52 billion slightly exceeded the $3.48 billion estimate . Standalone profi
RTX Corporation (NYSE: RTX) is projected to report Q3 2026 earnings of $1.78 per share on revenue of approximately $24.10 billion . The company has a strong track record, beating earnings estimates for four consecutive quarters, and its shares have climbed 18.4% over the past yea
GreenPower Motor Company (NASDAQ: GP) completed a 5-for-1 reverse stock split on October 19, 2026, to address NASDAQ compliance issues. This action was taken after the company's shares traded below NASDAQ's $1 minimum bid price for 30 consecutive business days . The reverse split
Roth Capital increased its price target for Chord Energy to $165 , citing robust operational results and strong energy sector performance. Chord Energy reported preliminary Q3 2026 production exceeding forecasts, with capital spending within budget and strong adjusted free cash f
MDA Space (OTC: MDALF) receives an "Outperform" rating from RBC Capital (NYSE: RY) , despite a revised price target, indicating a positive investment outlook for the space technology stock . MDA Space is preparing to release its third-quarter financial results on November 5, 2026
A company officer at Signet Jewelers (NYSE:SIG) executed significant insider stock sales in mid-October. These transactions were conducted under a prearranged Rule 10b5-1 trading plan , which allows insiders to schedule trades in advance. The article also provides a snapshot of S
BMO Capital has raised its price target for Disc Medicine to $120 from $100 , maintaining an Outperform rating on the biotechnology stock. Positive Phase 3 clinical trial results for bitopertin in erythropoietic protoporphyria met both primary endpoints, demonstrating efficacy an
Qualcomm executive Ann C. Chaplin sold 1,827 shares for a total of $319,268.25 under a Rule 10b5-1 trading plan. Qualcomm's stock opened at $172.11 , below its 50-day moving average of $175.02 and 200-day moving average of $179.70 . Key financial ratios for Qualcomm include a tra
Analysts forecast BOK Financial to report Q3 2026 earnings per share between $2.52 and $2.54 , with revenue estimates around $571 million . The company has a strong track record, beating earnings estimates in its last two quarters with an average surprise of 6.67% . Key valuation
EyePoint (NASDAQ: EYPT) faced a significant setback as its DURAVYU treatment failed to meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD), leading to a sharp stock price decline and a reduced price target from Citigroup. Despite not me
A Marvell Technology executive sold 3,685 shares for approximately $865,864.00, reducing their stake to 58,748 shares. The sale coincides with market pressure on custom AI chip stocks, following warnings from Broadcom's CEO about AI funding. Despite strong AI-related results, Mar
Q3 2026 EPS Miss: Dynex Capital (NYSE:DX) reported earnings per share of $0.38 , slightly below the analyst estimate of $0.39 . Significant Revenue Shortfall: The company's revenue of $101.60 million fell short of the $113.50 million estimate, indicating a substantial miss in top
W.R. Berkley (NYSE: WRB) is set to announce its third-quarter 2026 earnings on October 19, with analysts forecasting earnings per share (EPS) of $1.15 and revenue of $3.82 billion . Consensus estimates suggest EPS growth of 3.6% and revenue growth of 3.1% year-over-year, reflecti
Headlines provided by Investing.com